GRAS Notices
-
GRN No. 831
Bacillus subtilis DE111
Intended Use: | Ingredient in cows-milk and soy-based non-exempt infant formula for term infants at a maximum level of 2 x 10^8 colony forming units (CFU)/100 mL and in baked goods and baking mixes; beverages and beverage bases; breakfast cereals; chewing gum; coffee and tea; condiments and relishes; confections and frostings; dairy product analogs; fats and oils; fruit juices; frozen dairy desserts and mixes; fruit and water ices; gelatins, puddings, and fillings; grain products and pastas; soft/hard candy and cough drops; herbs, seeds, spices, seasonings, blends, extracts, and flavorings; jams and jellies; milk and milk products; nuts and nut products; plant protein products; processed fruits; processed vegetables and vegetable juices; snack foods; soups and soup mixes;1 sugar; and sweet sauces, toppings, and syrups at levels from 1 x 10^6 to 1 x 10^10 CFU/serving. |
---|---|
Basis: | Scientific procedures |
Notifier: | Deerland Probiotics and Enzymes |
Notifier Address: | 3800 Cobb International Blvd Kennesaw, GA 30152 |
GRAS Notice (releasable information): | GRN 831 with amendments (in PDF) (6.4 MB) |
Date of closure: | Aug 13, 2019 |
Date of FDA’s corrected letter: | Oct 7, 2019 |
FDA's Letter: | FDA has no questions (in PDF) (73 kB) |
-